Shares & the stockmarket
FTSE 100 Changes: Is Computacenter an AI Signal?
FTSE 100 changes are back in focus — but does Computacenter joining the index signal a stronger UK technology sector, or a warning from market history?
In this video, Russ Mould explores the latest FTSE 100 reshuffle, including why Computacenter, Aberdeen, and Investec are being promoted, while companies such as Rightmove, Berkeley, and Mondi move down to the FTSE 250.
More importantly, what does this tell us about the UK stock market, investor sentiment, and growing interest in AI-related businesses?
Russ examines whether Computacenter’s promotion reflects genuine long-term growth linked to data centre investment and artificial intelligence — or whether investors should remember lessons from previous market themes, including the technology boom of the late 1990s and commodity surges of the 2000s.
In this video:
- The latest FTSE 100 changes explained
- Why Computacenter’s promotion matters
- How AI infrastructure spending is influencing markets
- Lessons from previous sector booms and busts
- What this could mean for UK investors
Related videos:
4 June 2026
This 5% rate shock could change your finances
28 May 2026
Would markets care if the Prime Minister changed tomorrow?Political uncertainty often dominates the news cycle - but what does it actually mean for investors...
21 May 2026
Why UK stocks are being targeted for takeoversThe UK stock market takeover boom is gathering pace in 2026, with companies including Tate & Lyle...
15 May 2026
The S&P 500 at new all-time highs and eyes are on NVIDIANVIDIA earnings are once again in focus as investors look for confirmation that the AI-driven rally...
8 May 2026
Why are housebuilders’ shares crumbling?UK housebuilder shares have fallen sharply—but what’s driving the decline, and what could change...
30 April 2026
Consumer staples stocks 2026: what’s going wrong?Consumer staples stocks in 2026 are not behaving as expected. Russ Mould explains why traditionally...
24 April 2026
Big pharma in focus: What’s driving AstraZeneca and GSK right nowAstraZeneca results are in focus as the FTSE 100 earnings season accelerates. With pharma stocks...